Ionis Reaches Phase 3 Enrollment Milestone for Obudanersen
CARLSBAD, Calif., July 6, 2026 Ionis Pharmaceuticals announced the completion of enrollment for the pivotal pediatric cohort of its...
Angelman Syndrome
Advertisement
Encoded Therapeutics Expands CNS Gene Therapy Pipeline
SOUTH SAN FRANCISCO, Calif., May 12, 2026 Encoded Therapeutics announced new preclinical findings at the 2026 American Society of...
Encoded Therapeutics Showcases ETX101 Data at ASGCT
SOUTH SAN FRANCISCO, Calif., April 27, 2026 Encoded Therapeutics announced its participation in the 29th Annual Meeting of the...
MavriX Bio Doses First Patient in Landmark ASCEND-AS Gene Therapy Trial
Middleton, Massachusetts – November 6, 2025 – MavriX Bio, a clinical-stage biotechnology company focused on transformative genetic medicines, announced...
Advertisement
